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Introduction.  Septic purulent infections with methicilin-resistant Staphylococcus (MRS) is 
an important public health problem due to the high number of illness and significant health and 
socio-economic impact. It is recognized as one of the most common causes of nosocomial 
infections. In the Republic of Moldova the true incidence of septic-purulent nosocomial 
infections caused by methicillin-resistant Staphylococcus (MRS) is not known. 
Aim of the study. To determine the incidence and epidemiological particularities of septic-
purulent infections caused by MRS. 
Materials and methods. The study includes the results of bacteriological investigations of 
patients from the multi-profile medical institutions, rural and maternity hospitals. The isolation 
of Staphylococcal strains and determination of their sensitivity to antibiotics were carried out 
by using the classical method and the automated system VITEK 2 Compact (bioMérieux). 
Results.  Results of this study showed that in Moldova the spread of MRS is diverse, in the 
multi-profile medical hospitals – 36,32%, maternity – 61,81%, rural – 22,36%. In 72,13% of 
cases, strain of methicillin-resistant Staphylococcus are coagulase-negative staphylococci, and 
only 27,87% - are coagulase-positive staphylococci. Polyresistant strains of MRS to antibiotics 
are increasing, from 78,96% in 2014 to 89,89% in 2017. The prevalence of MRS strains varied 
depending on the profile of the hospital division and pathological products. A higher isolation 
rate of MRS strains were seen in patients admitted to the surgical wards, intensive care unit, 
traumatology and orthopedics, while 76,11% strains were isolated from blood cultures. 
Conclusions.  Septic purulent Infections with MRS in Moldova is a major public health 
problem. The results of the study show that the share of MRS strains is ~ 36,32%. 
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Introduction.  Acinetobacter baumannii infections are a growing clinical problem affecting all 
countries of the world. Given the distinct survival ability, Acinetobacter baumannii is easily 
spread in the hospital environment causing nosocomial infections. The risk factors for A. 
baumannii infection include hospitalisation, poor overall condition, circulatory system 
insufficiency, respiratory system insufficiency, mechanical ventilation, prior antibiotic therapy 
and presence of foreign materials (such as venous, arterial and urinary catheters). More than 
30% of hospital-acquired infections are due to Acinetobacter baumannii, and it can cause 
various types of infections, mostly related to intensive care and invasive treatments (ventilator-
associated pneumonia (47% cases), bloodstream infections, surgical site infections, urinary 
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tract infections (45% cases), skin and soft tissue infections, meningitis). For decades the genus 
Acinetobacter has undergone several taxonomical modifications. In the last few years these 
organisms are genetically modifying into highly resistant forms resulting in untreatable 
nosocomial infections and health care associated infections. A. baumannii can cause severe or 
fatal illnesses, especially in critically ill patients with low immune responses, and can increase 
patient mortality along with hospital costs.  Studies show that the mortality rate of hospitalised 
patients infected with A. baumannii is 8-23%, and 10-43% at intensive care units. 
Aim of the study. Determining the degree of spread of nosocomial infections caused by 
Acinetobacter spp., nosological structure, epidemiological features, antibiotic resistance. 
Materials and methods.  A descriptive cross-sectional study was conducted for 2014–2016 
on the model of the Republican Clinical Hospital, the Institute of Neurology and Neurosurgery, 
and the Institute of Emergency Medicine. 
Results.  In 2014-2016, in the three hospitals mentioned above, 1,005 cases of purulent-septic 
infections caused by Acinetobacter spp. were investigated. Most often they are found in 
intensive care units, anesthesiology and intensive care (56.32%), surgery (15.72%) and 
traumatology and orthopedic (14, 82%).  The largest share is occupied by A. baumannii 
(98.69%), compared with A. iwoffii (0.95%) and A. haemolyticus (0.36%). Acinetobacter 
strains are mainly found in monocultures (65.77%), but in 34.23% - in associations in which 
gram-negative microorganisms significantly prevail (79.86%), including P. aeruginosa 
(33.49%), K pneumoniae (17.33%) and E. coli (11.48%).  In 81.13%, Acinetobacter strains are 
resistant to antibiotics, and only 18.87% are sensitive to them. Acinetobacter strains were more 
resistant to penicillins (97.02%), penicillins + beta-lactamase inhibitors (96.73%), 
cephalosporins I generation (99.40%), cephalosporins II generation (98.86%), cephalosporins 
III generations (97.44%), IV generation cephalosporins (93.88%), nitrofurans (98.97%), 
macrolides (94.38%). A higher sensitivity is manifested in the following groups of antibiotics: 
cyclic polypeptides (94.42%), tetracyclines (85.12%) and other antibacterial agents (50.96%). 
Conclusions.  Most infections caused by Acinetobacter baumannii have been detected in 
patients hospitalized in intensive care units and surgical departments. Acinetobacter baumannii 
is resistant to most antibiotics, and sensitivity to the currently used antibiotics is significantly 
reduced. High prevalence of antibiotic-resistant strains of Acinetobacter spp. emphasizes the 
importance of the use of selective antibiotic therapy and the strict monitoring of measures to 
combat nosocomial infections. 
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Introduction. Vaccination is the most effective means of influenza prevention. The current 
epidemiological influenza situation in the world indicates that trivalent vaccines are not able to 
protect the population from all circulating strains of type B influenza virus, that necessitates 
the improvement and expansion of the composition of the vaccines.  
